Gilead Sciences, Inc.

NASDAQ:GILD

112.46 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199219911990
Revenue 28,75427,11627,28127,30524,68922,44922,12726,10730,39032,63924,89011,2029,7028,385.3857,949.427,011.3835,335.754,230.0453,026.1392,028.41,324.621867.864466.79233.769195.555169151.1132.333.42.74.94.22.81.3
Cost of Revenue 6,2516,4985,6576,6014,5724,6754,8534,3714,2614,0063,7882,8592,4712,124.411,869.8761,595.5581,127.246768.771433.32260.326166.587112.69169.72443.76433.51216.910.26.4-3.6-3.2-3.9-1.7-1-0.8
Gross Profit 22,50320,61821,62420,70420,11717,77417,27421,73626,12928,63321,1028,3437,2316,260.9756,079.5445,415.8254,208.5043,461.2742,592.8191,768.0741,158.034755.173397.066190.005162.043152.1140.9125.9375.98.85.93.82.1
Gross Profit Ratio 0.7830.760.7930.7580.8150.7920.7810.8330.860.8770.8480.7450.7450.7470.7650.7720.7890.8180.8570.8720.8740.870.8510.8130.8290.90.9320.9521.1082.1851.7961.4051.3571.615
Reseach & Development Expenses 5,9075,7184,9774,6015,0394,0553,9203,7345,0983,0142,8542,1201,7601,229.1511,072.93939.918721.768591.026383.861277.724223.552164.873134.758185.553132.339112.9127.8112.241.9030.4000
General & Administrative Expenses 2,6382,81800000000000000000000000000000000
Selling & Marketing Expenses 3,4533,27200000000000000000000000000000000
SG&A 6,0916,0905,6735,2465,1514,3814,0563,8783,3983,4262,9831,6991,4611,241.9831,044.392946.686797.344705.741573.66381.283307.095250.157181.301125.14182.02278.378.270.626.734.79.722.49.16.1
Other Expenses 8,8431,2053,6449395,856000000000000000010.21900012.613.215.24.53.23.91.710.8
Operating Expenses 20,84113,01314,29410,78616,0468,4367,9767,6128,4966,4405,8373,8193,2212,471.1342,117.3221,886.6041,519.1121,296.767957.521659.007530.647425.249316.059310.694214.361203.8219.219873.137.94424.110.16.9
Operating Income 1,6627,6057,3309,9184,0714,2878,20014,12417,63322,19315,2654,5244,0103,789.8413,962.2223,529.2212,678.5412,164.507-758.7531,109.067627.387-158.67581.007-120.689-52.318-51.7-78.3-72.1-36.1-32-35.2-18.2-6.3-4.8
Operating Income Ratio 0.0580.280.2690.3630.1650.1910.3710.5410.580.680.6130.4040.4130.4520.4980.5030.5020.512-0.2510.5470.474-0.1830.174-0.516-0.268-0.306-0.518-0.545-1.081-11.852-7.184-4.333-2.25-3.692
Total Other Income Expenses Net -972-746-1,516-1,640-2,402873-401-595-536-534-409-316-398-138.837-48.674-27.265-5.843105.831120.54652.72529.035-8.858-7.61178.13610.411-13.934.4-0.536.13235.218.26.34.8
Income Before Tax 6906,8595,8148,2781,6695,1607,79913,52917,09721,65914,8564,2083,6123,651.0043,913.5483,501.9562,672.6982,270.338-638.2071,161.792656.422-167.53373.39757.447-41.907-65.6-43.9-72.6000000
Income Before Tax Ratio 0.0240.2530.2130.3030.0680.230.3520.5180.5630.6640.5970.3760.3720.4350.4920.4990.5010.537-0.2110.5730.496-0.1930.1570.246-0.214-0.388-0.291-0.549000000
Income Tax Expense 2111,2471,2482,0771,580-2042,3398,8853,6093,5532,7971,1511,038861.9451,023.799876.364702.363655.04551.75347.878207.051-95.531.34.1351.1990.90.90.3000000
Net Income 4805,6654,5926,2251235,3865,4554,62813,50118,10812,1013,0752,5922,803.6372,901.2572,635.7551,978.8991,615.298-1,189.957813.914449.371-72.00372.09752.271-56.776-66.5-44.8-72.9-21.7-27.4-31.3-14.1-4.5-4
Net Income Ratio 0.0170.2090.1680.2280.0050.240.2470.1770.4440.5550.4860.2750.2670.3340.3650.3760.3710.382-0.3930.4010.339-0.0830.1540.224-0.29-0.393-0.296-0.551-0.65-10.148-6.388-3.357-1.607-3.077
EPS 0.384.543.664.960.0714.244.23.5410.0812.377.952.011.711.811.71.461.090.87-0.650.450.26-0.0450.0460.035-0.039-0.049-0.043-0.027-0.024-0.04-0.043-0.028-0.013-0.013
EPS Diluted 0.384.53.644.930.0714.224.173.519.9411.917.351.811.641.781.661.411.050.84-0.650.430.25-0.0450.0440.033-0.039-0.049-0.043-0.027-0.024-0.04-0.043-0.028-0.013-0.013
EBITDA 4,43410,4968,85211,3294,1337,55910,30515,93319,21923,44516,3184,8604,2514,158.6544,287.9863,784.5622,893.5522,215.7861,682.5821,144.844651.795350.78395.435-105.998-40.31-39.1-65.1-56.9-31.6-28.8-31.3-16.5-5.3-4
EBITDA Ratio 0.1540.3870.3240.4150.1670.3370.4660.610.6320.7180.6560.4340.4380.4960.5390.540.5420.5240.5560.5640.4920.4040.204-0.453-0.206-0.231-0.431-0.43-0.946-10.667-6.388-3.929-1.893-3.077